This new patent offers automated viable monitoring in the aseptic filling process, which reduces manual interventions for environmental monitoring by 80 percent.
CE mark of these next-generation cardiac imaging systems will further enable connected care along the cardiology patient journey and provide clinicians with the tools to deliver more efficient and timely care.
ZEISS extends its global refractive industry momentum with more than 10 million eyes treated with ZEISS SMILE and ZEISS SMILE pro; announces first treatment in the CE market for hyperopia with lenticule extraction using ZEISS SMILE pro technology.
Genvor will receive year-long access to lab space and equipment at Bayer’s LifeHub California @AgStart, one of the premier U.S. AgriFoodTech innovation ecosystems.
The ACURATE Prime valve system is designed with several features to build upon the clinical performance of the ACURATE neo2 platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.
ZEISS launches its latest innovation in the field of X-ray microscopy: ZEISS VersaXRM 730®. The new system offers researchers an unprecedented level of performance, choice, and accessibility.
Getinge announces an agreement to acquire 100% of Paragonix Technologies, Inc., a leading organ transport products and services company in the United States.